DENTSPLY SIRONA Management
Management criteria checks 2/4
DENTSPLY SIRONA's CEO is Simon Campion, appointed in Sep 2022, has a tenure of 2.25 years. total yearly compensation is $8.52M, comprised of 11.7% salary and 88.3% bonuses, including company stock and options. directly owns 0.059% of the company’s shares, worth $2.19M. The average tenure of the management team and the board of directors is 1.2 years and 4.8 years respectively.
Key information
Simon Campion
Chief executive officer
US$8.5m
Total compensation
| CEO salary percentage | 11.7% |
| CEO tenure | 2.3yrs |
| CEO ownership | 0.06% |
| Management average tenure | 1.2yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Is Now An Opportune Moment To Examine DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?
Dec 21
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 40% Below Their Intrinsic Value Estimate
Dec 03Dentsply Sirona: No Change To Operating Mechanics Despite Extensive Review
Nov 27DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Nov 11DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns
Oct 13DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough
Sep 25Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?
Sep 05Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?
Aug 18Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes
Jul 11A Tough Macro Environment Makes Dentsply Sirona's Turnaround Even Harder
Jul 02Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price
Jun 11We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt
May 24Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader
Apr 24Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?
Apr 22There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues
Mar 10Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden
Feb 16DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward
Jan 29DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate
Jan 11Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?
Nov 25These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively
Nov 06Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture
Oct 15An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued
Sep 18DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet
Jul 31The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing
Jul 09A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)
Jun 20When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?
Jun 02Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel
May 15The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing
Apr 05Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?
Mar 07We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt
Nov 09Dentsply Sirona names Glenn Coleman as new CFO
Sep 22Dentsply Sirona hires Simon Campion as president, CEO
Aug 25CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$413m |
| Jun 30 2024 | n/a | n/a | -US$185m |
| Mar 31 2024 | n/a | n/a | -US$95m |
| Dec 31 2023 | US$9m | US$1m | -US$132m |
| Sep 30 2023 | n/a | n/a | -US$214m |
| Jun 30 2023 | n/a | n/a | -US$1b |
| Mar 31 2023 | n/a | n/a | -US$1b |
| Dec 31 2022 | US$8m | US$304k | -US$950m |
Compensation vs Market: Simon's total compensation ($USD8.52M) is about average for companies of similar size in the US market ($USD6.67M).
Compensation vs Earnings: Simon's compensation has increased whilst the company is unprofitable.
CEO
Simon Campion (53 yo)
2.3yrs
Tenure
US$8,518,987
Compensation
Mr. Simon D. Campion serves as Chief Executive Officer at DENTSPLY SIRONA Inc. since September 12, 2022 and also serves as its President & Director since September 2022 & was its Interim CFO since November...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$8.52m | 0.059% $ 2.2m | |
| Executive VP of Corporate Development | 1.8yrs | US$4.35m | 0.0053% $ 197.8k | |
| Senior VP & Chief Supply Chain Officer and Head of Sustainability | less than a year | US$2.94m | 0.020% $ 754.6k | |
| Interim Chief Financial Officer | no data | no data | no data | |
| Vice President & Chief Accounting Office | less than a year | no data | 0.0029% $ 109.3k | |
| Senior VP & Chief Technology Officer | less than a year | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Senior VP & Chief Human Resources Officer | 1.4yrs | no data | 0.00092% $ 34.2k | |
| Senior VP of Global Quality and Regulatory & Chief Quality Officer | 1.6yrs | no data | no data | |
| Treasurer | no data | no data | no data | |
| Attorney-In-Fact | no data | no data | no data | |
| Group Vice President for EMEA RCO | no data | no data | no data |
1.2yrs
Average Tenure
53.5yo
Average Age
Experienced Management: XRAY's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$8.52m | 0.059% $ 2.2m | |
| Independent Director | 4.3yrs | US$300.00k | 0.0092% $ 342.0k | |
| Independent Director | 6.9yrs | US$315.00k | 0.0014% $ 50.9k | |
| Independent Director | 6.9yrs | US$325.00k | 0.013% $ 478.0k | |
| Independent Director | less than a year | US$25.00k | no data | |
| Independent Chairman | 5.6yrs | US$318.75k | 0.038% $ 1.4m | |
| Independent Director | 13.8yrs | US$320.00k | 0.018% $ 656.5k | |
| Independent Director | 5.3yrs | US$315.00k | 0.011% $ 408.5k | |
| Independent Director | 2.8yrs | US$310.00k | 0.0042% $ 156.9k | |
| Independent Director | 1.6yrs | US$260.44k | 0.0028% $ 103.0k |
4.8yrs
Average Tenure
61.5yo
Average Age
Experienced Board: XRAY's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:43 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DENTSPLY SIRONA Inc. is covered by 39 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | Baird |
| Jeffrey Johnson | Baird |
| Ishan Majumdar | Baptista Research |